Skye Bioscience Other Long Term Assets (Quarterly) Analysis

Skye Bioscience, Inc. (SKYE)

0.9729 -0.03 (-2.71%) USD | NASDAQ | Jan 20, 16:00

0.98 +0.01 (+0.73%) After-Hours: 06:58

View Other Long Term Assets (Quarterly) for SKYE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Perspective Therapeutics, Inc.	Upgrade
Theravance Biopharma, Inc.	Upgrade
Viking Therapeutics, Inc.	--
Kyntra Bio, Inc.	Upgrade
Myomo, Inc.	Upgrade